Skip to main content
Invivyd, Inc. logo

Invivyd, Inc. — Investor Relations & Filings

Ticker · IVVD ISIN · US00534A1025 US Manufacturing
Filings indexed 403 across all filing types
Latest filing 2026-05-14 Registration Form
Country US United States of America
Listing US IVVD

About Invivyd, Inc.

https://invivyd.com/

Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for serious viral infectious diseases. The company's mission is to rapidly and continually deliver therapies that keep pace with evolving viral threats. Utilizing a proprietary technology platform, Invivyd develops monoclonal antibody candidates designed to be more potent and resistant to virus evolution than the human immune system. Its pipeline is initially focused on addressing SARS-CoV-2, with plans to expand into other high-need indications such as influenza.

Recent filings

Filing Released Lang Actions
S-8
Registration Form
2026-05-14 English
10-Q
Interim / Quarterly Report
2026-05-14 English
8-K
Regulatory Filings
2026-05-14 English
8-K - Invivyd, Inc. (0001832038) (Filer)
Regulatory Filings
2026-04-09 English
ARS - Invivyd, Inc. (0001832038) (Filer)
Annual Report
2026-04-06 English
DEF 14A - Invivyd, Inc. (0001832038) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.